M&G European Index Tracker A

European equity fund tracking the FTSE Europe ex UK index.

  • 84.72p
    Price (Inc)

    These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.

  • 131.55p
    Price (Acc)

    These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?

  • 0.00%

    Initial charge

    Some funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!

  • 0.50%
    Annual management charge

    This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).

  • 0.70%
    Ongoing charges

    This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.

  • 3.00%
    Yield

    How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…

Prices as at 21 September 2020

The Fund aims to track the performance of the FTSE World Europe ex UK Index, which represents a broad spread of European equities. It will typically hold around 350 stocks, including the largest 100 stocks in the index, as well as a selection of the remaining smaller stocks to ensure that the fund’s market capitalisation and industry weights are in line with the index weighting.

Fund summary

Sector Europe Excluding UK
Structure OEIC
Launched January, 2000
Size £79m
Yield 3.00%
Charging basis
Dividends paid 31 Oct

Charges

Standard initial charge 0.00%
Initial charge via Bestinvest 0.00%
Additional bid/offer spread 0.00%
Annual management charge 0.50%
Ongoing charges figure 0.70%

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Investment process

Manager research

Average monthly relative returns

  • 15/16 -0.15%
  • 16/17 -0.06%
  • 17/18 -0.07%
  • 18/19 -0.12%
  • 19/20 0.01%

Bestinvest MRI

  • 3 years -0.06%
  • 5 years -0.08%
  • Career -0.07%
  • 3 years 50.00%
  • 5 years 43.60%
  • Career 47.20%

Performance figures are based on the average of monthly percentage returns relative to the benchmark index.

Nigel Booth

Booth joined the Equity Structured Products desk in August 2003 as Head of Index Funds and is responsible for passive funds and low risk active funds. He started his career in the City in 1983 working in the research department of the stock-jobbing firm Wedd Durlacher Mordaunt, which subsequently merged with Barclays Merchant Bank and De Zoete & Bevan, forming BZW. In 1988 he left BZW joining the Investment Management arm of Equitable Life Assurance Society working as an Analyst / Fund Manager, initially covering larger companies but later specialising in Mid Cap stocks. Booth joined Clerical Medical Investment Management (now Insight Investment) in April 2001, where he was responsible for passive funds, and derivatives dealing, including futures, index options and contracts for difference. He graduated from Kingston Polytechnic with an upper second class degree in Business Studies in 1983 and passed the Stock Exchange Practice examination in November 1984.

Track record

Nigel Booth has 17.1 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been -0.07%. During the worst period of relative performance (from August 2003 - February 2020) there was a decline of 16% relative to the index. The worst absolute loss has been 42%.

Periods of worst performance

Absolute -42.00% (December 2007 - February 2009)
Relative -16.00% (August 2003 - February 2020)

About the MRI

Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Top 10 holdings

Data accurate as at 31 July 2020

5% Nestle Sa
3.7% Roche Hldg Ag
2.6% Novartis Ag
2.6% Sap Se
2.1% Asml Holding Nv
1.7% Sanofi
1.6% Novo-Nordisk As
1.6% Lvmh Moet Hennessy Vuitton Se
1.4% Siemens Ag
1.3% Total Se
Source: Trustnet

Sector breakdown

Consumer Goods 19.00%
Health Care 17.00%
Financials 17.00%
Industrials 16.00%
Technology 9.00%
Basic Materials 5.00%
Utilities 5.00%
Consumer Services 4.00%
Oil & Gas 4.00%
Telecommunications 3.00%

Key Investor Information - Income

Download

Key Investor Information - Accumulation

Download